|
Due to the region’s enormous recruitment potential and
steep enrollment curves, Sticares InterACT
has always been focused on Central & Eastern Europe.
Our global reach is guaranteed by GlobalACT, our
strategic alliance with partner organizations in North America, South
America, South Africa and Australasia.
For a global trial we act as one CRO, in practice you will have just one
contact.
In Central & Eastern Europe our investigator
networks have easy access to a large pool of potential clinical trial
subjects. Investigators have shown to be highly motivated to participate in
clinical trials. Moreover, high patient compliance and retention are
guaranteed, and quality data is obtained at a relatively low cost.
In addition, there are also various good reasons to
conduct clinical trials in Western Europe.
Many key opinion leaders (KOLs) find their common ground in this part of Europe.
Also, most Western European countries are capable of delivering significant
numbers of clinical trial subjects. Another reason is that it is often
necessary to balance a trial in terms of populations or certain population
characteristic(s) in a geographically wider trial.
Clinical trial practices and procedures throughout Europe
have been harmonized but still differ significantly among countries. Due to our
long term presence in Central, Eastern and Western Europe, Sticares
InterACT
has a robust insight in clinical trial practices & procedures in
each country. Our
dedicated staff
is based throughout Europe and all communication with investigators, suppliers
and regulatory bodies is in the
native language.
| 
